FDA inspection
Atomvie Global Radiopharma Inc.: FDA inspection ending Mar 27, 2018
FDA inspection 1045820 · Official Action Indicated (OAI) · Hamilton
Key facts
| Inspection ID | 1045820 |
|---|---|
| Firm | Atomvie Global Radiopharma Inc. |
| FEI number | 3007998963 |
| Address | Nrb A316, 1-1280 Main St W |
| City | Hamilton |
| Country | Canada |
| Fiscal year | 2018 |
| Inspection end date | Mar 27, 2018 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data